GCC Countries Radiopharmaceutical Market Report

Europe GCC Countries Radiopharmaceutical Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 29, 2020
  • PAGES：192
  • REPORT CODE：GMM525736
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The GCC Countries Radiopharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe GCC Countries Radiopharmaceutical Market Segmentations:

    By Player:

    • Lantheus

    • Triad Isotopes

    • GE Healthcare

    • Advanced Accelerator Applications

    • Mallinckrodt

    • SIEMENS

    • Jubilant Pharma

    • Bracco Imaging

    • China Isotope & Radiation

    • IBA Group

    • Bayer

    • Nordion

    • Dongcheng

    • Navidea

    • Eli Lilly

    By Type:

    • Actinium-225

    • Lutetium-177

    • Radium-223

    • Holmium-166

    • Other

    By End-User:

    • Other

    • Other

    • Other

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of GCC Countries Radiopharmaceutical Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Actinium-225 from 2014 to 2026

    • 1.3.2 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

    • 1.3.3 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Radium-223 from 2014 to 2026

    • 1.3.4 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Holmium-166 from 2014 to 2026

    • 1.3.5 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4.2 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4.3 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4.4 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of GCC Countries Radiopharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of GCC Countries Radiopharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of Actinium-225

      • 3.4.2 Market Size and Growth Rate of Lutetium-177

      • 3.4.3 Market Size and Growth Rate of Radium-223

      • 3.4.4 Market Size and Growth Rate of Holmium-166

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of GCC Countries Radiopharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of GCC Countries Radiopharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of GCC Countries Radiopharmaceutical for Other

      • 4.4.2 Market Size and Growth Rate of GCC Countries Radiopharmaceutical for Other

      • 4.4.3 Market Size and Growth Rate of GCC Countries Radiopharmaceutical for Other

      • 4.4.4 Market Size and Growth Rate of GCC Countries Radiopharmaceutical for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe GCC Countries Radiopharmaceutical Production Analysis by Top Regions

    • 5.2 Europe GCC Countries Radiopharmaceutical Consumption Analysis by Top Regions

    • 5.3 Europe GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.2 UK GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 France GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Circulation of GCC Countries Radiopharmaceutical Market among Top Countries

    • 6.1 Top 5 Export Countries in GCC Countries Radiopharmaceutical Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in GCC Countries Radiopharmaceutical Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany GCC Countries Radiopharmaceutical Landscape Analysis

    • 7.1 Germany GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 7.2 Germany GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    8. UK GCC Countries Radiopharmaceutical Landscape Analysis

    • 8.1 UK GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 8.2 UK GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    9. France GCC Countries Radiopharmaceutical Landscape Analysis

    • 9.1 France GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 9.2 France GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    10. Italy GCC Countries Radiopharmaceutical Landscape Analysis

    • 10.1 Italy GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 10.2 Italy GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    11. Spain GCC Countries Radiopharmaceutical Landscape Analysis

    • 11.1 Spain GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 11.2 Spain GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    12. Poland GCC Countries Radiopharmaceutical Landscape Analysis

    • 12.1 Poland GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 12.2 Poland GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    13. Russia GCC Countries Radiopharmaceutical Landscape Analysis

    • 13.1 Russia GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 13.2 Russia GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    14. Switzerland GCC Countries Radiopharmaceutical Landscape Analysis

    • 14.1 Switzerland GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 14.2 Switzerland GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    15. Turkey GCC Countries Radiopharmaceutical Landscape Analysis

    • 15.1 Turkey GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 15.2 Turkey GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Landscape Analysis by Top Countries

      • 16.3.1 Denmark GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.2 Finland GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.3 Norway GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.4 Sweden GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 16.3.6 Iceland GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Landscape Analysis by Top Countries

      • 17.3.1 Belgium GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 17.3.2 Netherlands GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 17.3.3 Luxembourg GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Landscape Analysis by Top Countries

      • 18.3.1 Estonia GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 18.3.2 Latvia GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 18.3.3 Lithuania GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Lantheus

      • 19.1.1 Lantheus Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Triad Isotopes

      • 19.2.1 Triad Isotopes Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GE Healthcare

      • 19.3.1 GE Healthcare Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Advanced Accelerator Applications

      • 19.4.1 Advanced Accelerator Applications Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Mallinckrodt

      • 19.5.1 Mallinckrodt Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 SIEMENS

      • 19.6.1 SIEMENS Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Jubilant Pharma

      • 19.7.1 Jubilant Pharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Bracco Imaging

      • 19.8.1 Bracco Imaging Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 China Isotope & Radiation

      • 19.9.1 China Isotope & Radiation Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 IBA Group

      • 19.10.1 IBA Group Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Bayer

      • 19.11.1 Bayer Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Nordion

      • 19.12.1 Nordion Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Dongcheng

      • 19.13.1 Dongcheng Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Navidea

      • 19.14.1 Navidea Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Eli Lilly

      • 19.15.1 Eli Lilly Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 69 Figures and 158 Tables)

    • Figure Product Picture

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Actinium-225 from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Radium-223 from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Holmium-166 from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure UK GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure France GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Italy GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Spain GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Poland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Russia GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Canada GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Finland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Norway GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of GCC Countries Radiopharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of GCC Countries Radiopharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of GCC Countries Radiopharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of GCC Countries Radiopharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Actinium-225

    • Figure Market Size and Growth Rate of Lutetium-177

    • Figure Market Size and Growth Rate of Radium-223

    • Figure Market Size and Growth Rate of Holmium-166

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of GCC Countries Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of GCC Countries Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Other

    • Figure Market Size and Growth Rate of Other

    • Figure Market Size and Growth Rate of Other

    • Figure Market Size and Growth Rate of Other

    • Table Europe GCC Countries Radiopharmaceutical Production by Major Regions

    • Table Europe GCC Countries Radiopharmaceutical Production Share by Major Regions

    • Figure Europe GCC Countries Radiopharmaceutical Production Share by Major Countries and Regions in 2014

    • Table Europe GCC Countries Radiopharmaceutical Consumption by Major Regions

    • Table Europe GCC Countries Radiopharmaceutical Consumption Share by Major Regions

    • Table Germany GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table UK GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table France GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Italy GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Spain GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Poland GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Russia GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Switzerland GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Turkey GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in GCC Countries Radiopharmaceutical Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Germany GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Germany GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Germany GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table UK GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table UK GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table UK GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table UK GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table France GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table France GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table France GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table France GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Italy GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Italy GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Italy GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Italy GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Spain GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Spain GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Spain GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Spain GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Poland GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Poland GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Poland GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Poland GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Russia GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Russia GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Russia GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Russia GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Switzerland GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Switzerland GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Switzerland GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Turkey GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Turkey GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Turkey GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Turkey GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US